Cubist Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Cubist Pharmaceuticals's estimated annual revenue is currently $49.6M per year.
- Cubist Pharmaceuticals's estimated revenue per employee is $201,000
- Cubist Pharmaceuticals has 247 Employees.
- Cubist Pharmaceuticals grew their employee count by -6% last year.
Cubist Pharmaceuticals Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Cubist Pharmaceuticals?
Effective January 22, 2015, Cubist Pharmaceuticals is now a wholly owned subsidiary of Merck & Co., Inc. For continued news and updates, we encourage you to follow Merck on LinkedIn at https://www.linkedin.com/company/merck to stay in touch and learn more.keywords:N/A
Number of Employees
Employee Growth %
Cubist Pharmaceuticals News
Previously, she was the COO at Dimension Therapeutics. Before that, she held several executive level roles at Cubist Pharmaceuticals,...
Prior to Tetraphase, he was chief commercial officer for Trius Therapeutics, which was acquired by Cubist Pharmaceuticals for more than $700...
... in the biotech and pharmaceutical industries to the company. ... was acquired by Cubist Pharmaceuticals for more than $700 million.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|